Annual ROA
-39.96%
+6.16%+13.36%
December 31, 2023
Summary
- As of February 7, 2025, RARE annual return on assets is -39.96%, with the most recent change of +6.16% (+13.36%) on December 31, 2023.
- During the last 3 years, RARE annual ROA has fallen by -27.07% (-210.01%).
- RARE annual ROA is now -210.01% below its all-time high of -12.89%, reached on December 31, 2020.
Performance
RARE ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROA
-38.86%
+3.14%+7.48%
September 30, 2024
Summary
- As of February 7, 2025, RARE quarterly return on assets is -38.86%, with the most recent change of +3.14% (+7.48%) on September 30, 2024.
- Over the past year, RARE quarterly ROA has increased by +5.90% (+13.18%).
- RARE quarterly ROA is now -596.42% below its all-time high of -5.58%, reached on December 31, 2012.
Performance
RARE Quarterly ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROA Formula
ROA = Net Income
Total Assets ✕ 100%
Total Assets ✕ 100%
RARE ROA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +13.4% | +13.2% |
| 3 y3 years | -210.0% | -66.6% |
| 5 y5 years | -22.4% | +15.2% |
RARE ROA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -44.4% | +13.4% | -34.8% | +22.6% |
| 5 y | 5-year | -210.0% | +13.4% | -179.6% | +22.6% |
| alltime | all time | -210.0% | +32.0% | -596.4% | +35.4% |
Ultragenyx Pharmaceutical ROA History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -38.86%(-7.5%) |
| Jun 2024 | - | -42.00%(-7.8%) |
| Mar 2024 | - | -45.56%(+4.7%) |
| Dec 2023 | -39.96%(-13.4%) | -43.52%(-2.8%) |
| Sep 2023 | - | -44.76%(-10.8%) |
| Jun 2023 | - | -50.20%(+1.3%) |
| Mar 2023 | - | -49.58%(+3.6%) |
| Dec 2022 | -46.12%(+66.7%) | -47.86%(+3.5%) |
| Sep 2022 | - | -46.25%(+32.1%) |
| Jun 2022 | - | -35.02%(+11.7%) |
| Mar 2022 | - | -31.34%(+8.7%) |
| Dec 2021 | -27.67%(+114.7%) | -28.82%(+23.6%) |
| Sep 2021 | - | -23.32%(-1.1%) |
| Jun 2021 | - | -23.58%(+66.1%) |
| Mar 2021 | - | -14.20%(+2.2%) |
| Dec 2020 | -12.89%(-70.3%) | -13.90%(-36.8%) |
| Sep 2020 | - | -21.98%(-19.2%) |
| Jun 2020 | - | -27.21%(-33.2%) |
| Mar 2020 | - | -40.75%(-4.9%) |
| Dec 2019 | -43.42%(+33.0%) | -42.83%(-6.5%) |
| Sep 2019 | - | -45.80%(+5.1%) |
| Jun 2019 | - | -43.58%(+10.5%) |
| Mar 2019 | - | -39.44%(+43.7%) |
| Dec 2018 | -32.65% | -27.45%(-5.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2018 | - | -28.89%(-4.0%) |
| Jun 2018 | - | -30.10%(-17.6%) |
| Mar 2018 | - | -36.53%(-39.3%) |
| Dec 2017 | -58.59%(+28.8%) | -60.19%(+4.6%) |
| Sep 2017 | - | -57.55%(+7.1%) |
| Jun 2017 | - | -53.73%(+7.1%) |
| Mar 2017 | - | -50.18%(+5.2%) |
| Dec 2016 | -45.48%(+74.8%) | -47.70%(+8.0%) |
| Sep 2016 | - | -44.18%(+17.3%) |
| Jun 2016 | - | -37.67%(+7.9%) |
| Mar 2016 | - | -34.90%(+11.5%) |
| Dec 2015 | -26.02%(-13.9%) | -31.31%(+9.5%) |
| Sep 2015 | - | -28.59%(-5.5%) |
| Jun 2015 | - | -30.24%(+3.8%) |
| Mar 2015 | - | -29.14%(-9.3%) |
| Dec 2014 | -30.21%(-48.6%) | -32.14%(-10.5%) |
| Sep 2014 | - | -35.90%(-11.4%) |
| Jun 2014 | - | -40.52%(-3.1%) |
| Mar 2014 | - | -41.83%(-23.5%) |
| Dec 2013 | -58.79%(+218.0%) | -54.69%(+49.6%) |
| Sep 2013 | - | -36.56%(+59.4%) |
| Jun 2013 | - | -22.93%(+73.6%) |
| Mar 2013 | - | -13.21%(+136.7%) |
| Dec 2012 | -18.49%(-67.3%) | -5.58% |
| Dec 2011 | -56.47% | - |
FAQ
- What is Ultragenyx Pharmaceutical annual return on assets?
- What is the all time high annual ROA for Ultragenyx Pharmaceutical?
- What is Ultragenyx Pharmaceutical annual ROA year-on-year change?
- What is Ultragenyx Pharmaceutical quarterly return on assets?
- What is the all time high quarterly ROA for Ultragenyx Pharmaceutical?
- What is Ultragenyx Pharmaceutical quarterly ROA year-on-year change?
What is Ultragenyx Pharmaceutical annual return on assets?
The current annual ROA of RARE is -39.96%
What is the all time high annual ROA for Ultragenyx Pharmaceutical?
Ultragenyx Pharmaceutical all-time high annual return on assets is -12.89%
What is Ultragenyx Pharmaceutical annual ROA year-on-year change?
Over the past year, RARE annual return on assets has changed by +6.16% (+13.36%)
What is Ultragenyx Pharmaceutical quarterly return on assets?
The current quarterly ROA of RARE is -38.86%
What is the all time high quarterly ROA for Ultragenyx Pharmaceutical?
Ultragenyx Pharmaceutical all-time high quarterly return on assets is -5.58%
What is Ultragenyx Pharmaceutical quarterly ROA year-on-year change?
Over the past year, RARE quarterly return on assets has changed by +5.90% (+13.18%)